Skip to Main Content

Paper Details

Polygenic hazard score is associated with prostate cancer in multi-ethnic populations.
Nat Commun
36
2021
PHS1, PHS2, PSA10ng, Polygenic, cancer, men, prostate cancer, prostate-cancer, prostate-cancer-specific death
Author NameAffiliation
Chun Chieh FanCenter for Multimodal Imaging and Genetics, University of California San Diego
Wesley K ThompsonDivision of Biostatistics and Halicioglu Data Science Institute, University of California San Diego
Wesley K ThompsonUniversity of California San Diego
Wesley K ThompsonDivision of Biostatistics and Halicioglu Data Science Institute, University of California San Diego
Wesley K ThompsonUniversity of California San Diego
Maria Elena MartinezMoores Cancer Center, University of California San Diego
Rosalind A EelesThe Institute of Cancer Research
Rosalind A EelesRoyal Marsden NHS Foundation Trust
Zsofia Kote-JaraiThe Institute of Cancer Research
Johanna SchleutkerInstitute of Biomedicine, FI-20014 University of Turku
Johanna SchleutkerTurku University Hospital
Johanna SchleutkerInstitute of Biomedicine, FI-20014 University of Turku
Johanna SchleutkerTurku University Hospital
Henrik Gr??nbergKarolinska Institute
Henrik Gr??nbergKarolinska Institute
David E NealUniversity of Oxford, John Radcliffe Hospital
David E NealUniversity of Cambridge, Addenbrooke's Hospital
David E NealCambridge Research Institute
Sune F NielsenUniversity of Copenhagen
Sune F NielsenHerlev and Gentofte Hospital, Copenhagen University Hospital
Børge G NordestgaardUniversity of Copenhagen
Børge G NordestgaardHerlev and Gentofte Hospital, Copenhagen University Hospital
Fredrik WiklundKarolinska Institute
Graham G Giles
Graham G GilesSchool of Clinical Sciences at Monash Health, Monash University
Graham G GilesThe University of Melbourne
Demetrius AlbanesNational Cancer Institute
Ruth C TravisUniversity of Oxford
William J BlotVanderbilt University Medical Center
William J BlotInternational Epidemiology Institute
Wei ZhengVanderbilt University Medical Center
Janet L StanfordFred Hutchinson Cancer Research Center
Janet L StanfordSchool of Public Health, University of Washington
Janet L StanfordFred Hutchinson Cancer Research Center
Janet L StanfordSchool of Public Health, University of Washington
Lorelei A MucciHarvard T. H. Chan School of Public Health
Catharine M L WestUniversity of Manchester, The Christie Hospital NHS Foundation Trust
Sonja I BerndtNational Cancer Institute
Cezary CybulskiInternational Hereditary Cancer Center, Pomeranian Medical University
Kay-Tee KhawClinical Gerontology Unit, University of Cambridge
Sue A InglesKeck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center
Stephen N ThibodeauMayo Clinic
Barry S RosensteinIcahn School of Medicine at Mount Sinai
Barry S RosensteinIcahn School of Medicine at Mount Sinai
Yong-Jie LuBarts Cancer Institute, Queen Mary University of London
Kathryn L PenneyBrigham and Women's Hospital/Harvard Medical School
Chad D HuffThe University of Texas M. D. Anderson Cancer Center
Robin J LeachMays Cancer Center, University of Texas Health Science Center at San Antonio
Esther M JohnStanford Cancer Institute, Stanford University School of Medicine
William S BushCase Western Reserve University, Cleveland Institute for Computational Biology
  • 1 - 50

Datasets